605177 东亚药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.1936.2905.8053.9288.883
总资产报酬率 ROA (%)0.7144.1704.4223.1627.182
投入资产回报率 ROIC (%)0.8124.7815.0983.6008.427

边际利润分析
销售毛利率 (%)25.40126.64022.81828.22933.969
营业利润率 (%)8.10910.09810.22411.08115.172
息税前利润/营业总收入 (%)7.6019.3478.5427.99614.631
净利润/营业总收入 (%)6.8188.9398.8539.61712.985

收益指标分析
经营活动净收益/利润总额(%)92.70393.95790.00376.01992.836
价值变动净收益/利润总额(%)6.7885.2186.8239.6250.000
营业外收支净额/利润总额(%)-2.229-1.692-4.778-2.416-2.750

偿债能力分析
流动比率 (X)2.4872.5032.0872.6104.412
速动比率 (X)1.5691.6131.2391.6763.559
资产负债率 (%)40.58339.72325.56721.90016.902
带息债务/全部投入资本 (%)29.01230.23210.4359.4412.641
股东权益/带息债务 (%)234.841224.801836.847935.9863,606.761
股东权益/负债合计 (%)146.408151.744291.124356.616491.646
利息保障倍数 (X)-22.984-16.028-7.030-2.832-108.522

营运能力分析
应收账款周转天数 (天)45.57431.74726.96744.49436.213
存货周转天数 (天)208.076199.681178.371241.874172.330